Patients with both HIV and multi-drug-resistant tuberculosis (MDR-TB) can now receive better-balanced medication. This may shorten the treatment duration for MDR-TB and reduce the many side effects associated with current ...
Sep 5, 2016
0
12
(Medical Xpress) -- When considering giving money to humanitarian crises people often donate in response to events that grab their immediate emotions, according to a recent study by CU-Boulder psychology professor Leaf Van ...
Jan 5, 2012
0
0
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million ...
Mar 28, 2016
0
40
Inaccurate tests carried out on tuberculosis patients in developing countries often fail to reliably detect resistance to drugs, leading to incorrect treatment and a higher mortality rate. These are the results of study by ...
Feb 8, 2019
0
0
Research, led by Timothy Sterling, M.D., professor of Medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis ...
Dec 9, 2011
0
0
India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
Mar 23, 2023
0
3
It's estimated that nearly one-third of the world's population -- more than two billion people -- are infected with Mycobacterium tuberculosis. According to the World Health Organization, 5 to 10 percent of infected people ...
Nov 16, 2011
0
0
(HealthDay)—A change of QuantiFERON-TB interferon (IFN)γ values from 0.7 IU/mL is associated with an increased incidence in the rate of tuberculosis, according to a study published online July 24 in the American Journal ...
Aug 4, 2017
0
0
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...
Oct 17, 2018
0
32
Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time—and ...
Feb 3, 2021
0
59
